INNOVA MED A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
Bankruptcy risk for industry  1.1% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 8.2% 3.6% 14.8% 7.5%  
Credit score (0-100)  0 32 54 15 34  
Credit rating  N/A BB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6

Net sales  0 0 0 0 0  
Gross profit  0.0 -116 7.7 -31.6 26.7  
EBITDA  0.0 -116 7.7 -31.6 26.7  
EBIT  0.0 -116 7.7 -31.6 26.7  
Pre-tax profit (PTP)  0.0 -134.0 53.8 -42.6 104.3  
Net earnings  0.0 -169.7 -25.5 -42.6 104.3  
Pre-tax profit without non-rec. items  0.0 -134 53.8 -42.6 104  

 
See the entire income statement

Balance sheet (kDKK) 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 579 554 511 615  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 1,072 1,017 782 822  

Net Debt  0.0 -827 -847 -538 -782  
 
See the entire balance sheet

Volume 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -116 7.7 -31.6 26.7  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 1,072 1,017 782 822  
Balance sheet change%  0.0% 0.0% -5.1% -23.1% 5.1%  
Added value  0.0 -116.3 7.7 -31.6 26.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 1.0 -1.0 1.0  

Profitability 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -12.5% 5.2% -3.0% 13.0%  
ROI %  0.0% -23.1% 9.5% -5.1% 18.5%  
ROE %  0.0% -29.3% -4.5% -8.0% 18.5%  

Solidity 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
Equity ratio %  0.0% 54.0% 54.4% 65.3% 74.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 711.0% -10,949.3% 1,702.5% -2,924.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
Quick Ratio  0.0 2.0 2.0 2.6 4.0  
Current Ratio  0.0 2.1 2.1 2.9 4.0  
Cash and cash equivalent  0.0 827.0 846.8 538.4 781.8  

Capital use efficiency 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 103.0 42.5 119.6 66.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -166.2 212.6 223.8 255.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2015
N/A
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0